FDA 483 - Newman Medical - May 31, 2019

An FDA inspection of Newman Medical in Arvada, CO, a medical device manufacturer, revealed significant deficiencies across its quality system. The firm failed to adequately establish procedures for finished device acceptance, complaint handling, corrective and preventive actions, vendor management, and incoming product acceptance. These issues indicate a systemic lack of control over critical manufacturing and quality processes.